TD Cowen Starts Upstream Bio (UPB) at Buy

November 5, 2024 5:30 AM EST Send to a Friend
TD Cowen analyst Yaron Werber initiates coverage on Upstream Bio (NASDAQ: UPB) with a Buy rating.The analyst comments "UPB's verekitug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login